Hims & Hers, The Telehealth Undervalued Sleeper Stock w/ Massive Longterm Upside copertina

Hims & Hers, The Telehealth Undervalued Sleeper Stock w/ Massive Longterm Upside

Hims & Hers, The Telehealth Undervalued Sleeper Stock w/ Massive Longterm Upside

Ascolta gratuitamente

Vedi i dettagli del titolo

3 mesi a soli 0,99 €/mese

Dopo 3 mesi, 9,99 €/mese. Si applicano termini e condizioni.

A proposito di questo titolo

Watch this episode on YouTube!

Hims & Hers is an American telehealth & telemedicine company. They sell prescription and over-the-counter drugs online, as well as personal care products. Hims & Hers is destigmatizing sexual health, hair loss/care, dermatology, and mental health, all of which are issues that people often feel intimidated to discuss in person, hence most conditions go untreated. The company’s digital, consumer-facing healthcare platform allows patients to seek care, meet with healthcare professionals through virtual appointments, and then pay to receive prescriptions and treatment products as part of a subscription.

🎙Get your 2 Minute Pump on the go via my podcast!

  • Apple Podcast: https://bit.ly/Apple-2MP
  • Spotify: https://bit.ly/Spotify-2MP
  • Amazon Music: https://bit.ly/Amazon-2MP
  • Google Podcast: https://bit.ly/Google-2MP
  • iHeart Radio: https://bit.ly/iHeart-2MP

Let's Connect:

  • Twitter: @2MinPump, www.twitter.com/2MinPump
  • Instagram: @2MinPump, www.instagram.com/2MinPump
  • Facebook: @2MinPump, www.facebook.com/2MinPump

Business Inquiries:

Dana Donovick | Disrupting, Co-Founder

  • 📧 Dana@Disrupting.news
  • 📍Seattle, WA
  • 🔗 www.Disrupting.news

⛔️Disclaimer: I'm not a licensed professional. This video is not financial advice. Dana Donovick & Disrupting aren't liable for any actions taken as a result of watching this video. The opinions shared by Dana Donovick are solely his own and are intended to entertain.

Ancora nessuna recensione